We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
-9.67%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
–
AUM
$2.05B
AUM Growth
+$174M
Cap. Flow
+$354M
Cap. Flow %
17.24%
Top 10 Hldgs %
26.45%
Holding
190
New
45
Increased
56
Reduced
57
Closed
32

Top Buys

Rank Stock Value
1
SOLV icon
Solventum
SOLV
+$50M
2
GPN icon
Global Payments
GPN
+$29.6M
3
APTV icon
Aptiv
APTV
+$29.1M
4
COUR icon
Coursera
COUR
+$23.9M
5
NEM icon
Newmont
NEM
+$23.2M

Top Sells

Rank Stock Value
1
MMM icon
3M
MMM
+$38.8M
2
ADM icon
Archer Daniels Midland
ADM
+$37.9M
3
CAG icon
Conagra Brands
CAG
+$25.2M
4
WEX icon
WEX
WEX
+$23M
5
SMAR
Smartsheet Inc.
SMAR
+$21.9M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 16.97%
2 Technology 15.71%
3 Healthcare 12.23%
4 Communication Services 9.72%
5 Energy 9.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SNDR icon
101
Schneider National
SNDR
$6.25B
$5.44M 0.26%
+224,973
New +$4.97M
HCAT icon
102
Health Catalyst
HCAT
$128M
$5.44M 0.26%
+850,581
New +$5.46M
FARO
103
DELISTED
Faro Technologies
FARO
$5.16M 0.25%
322,199
-17,212
-5% -$319K
BILL icon
104
BILL Holdings
BILL
$4.78B
$4.97M 0.24%
+94,469
New +$5.35M
FA icon
105
First Advantage
FA
$4.12B
$4.75M 0.23%
+295,855
New +$4.76M
XYZ
106
Block Inc
XYZ
$47.5B
$4.7M 0.23%
+72,917
New +$5.1M
AKAM icon
107
Akamai
AKAM
$15.9B
$4.5M 0.22%
+49,963
New +$4.83M
DOX icon
108
Amdocs
DOX
$6.22B
$4.46M 0.22%
+56,526
New +$4.65M
HSIC icon
109
Henry Schein
HSIC
$9.82B
$4.4M 0.21%
+68,583
New +$4.83M
VSH icon
110
Vishay Intertechnology
VSH
$5.43B
$4.36M 0.21%
195,596
+60,994
+45% +$1.38M
U icon
111
Unity
U
$18.9B
$4.33M 0.21%
+266,117
New +$5.69M
FIS icon
112
Fidelity National Information Services
FIS
$22.1B
$4.32M 0.21%
57,291
-2,155
-4% -$160K
CPA icon
113
Copa Holdings
CPA
$5.8B
$4.31M 0.21%
45,312
-77,991
-63% -$7.78M
NVEI
114
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
$4.22M 0.21%
130,478
-2,795
-2% -$90K
FIVE icon
115
Five Below
FIVE
$13.5B
$4.15M 0.2%
+38,114
New +$5.28M
CPRI icon
116
Capri Holdings
CPRI
$1.74B
$3.93M 0.19%
+118,783
New +$4.3M
UFI icon
117
UNIFI
UFI
$134M
$3.71M 0.18%
629,617
+7,341
+1% +$43.7K
IAS
118
DELISTED
Integral Ad Science
IAS
$3.61M 0.18%
+371,821
New +$3.56M
INMD icon
119
InMode
INMD
$880M
$3.59M 0.17%
+196,869
New +$3.62M
ALIT icon
120
Alight
ALIT
$407M
$3.49M 0.17%
23,646
-34,300
-59% -$5.71M
SMP icon
121
Standard Motor Products
SMP
$911M
$3.49M 0.17%
125,742
+75,665
+151% +$2.35M
SEI
122
Solaris Energy Infrastructure
SEI
$3.82B
$3.47M 0.17%
404,735
-10,685
-3% -$93.4K
BABA icon
123
Alibaba
BABA
$308B
$3.44M 0.17%
47,726
-62,275
-57% -$4.78M
PERI icon
124
Perion Network
PERI
$386M
$3.42M 0.17%
+410,179
New +$4.98M
RIVN icon
125
Rivian
RIVN
$23.2B
$3.39M 0.16%
+252,429
New +$2.64M
3 4
5
6 7

Similar funds

SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
CAG
Csenge Advisory Group Clearwater, Florida $2.18B AUM 16.73% 1-Year Est. Return
ORCP
One Rock Capital Partners New York $2.19B AUM
ET
Entropy Technologies New York $2.17B AUM 21.46% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
MIAS
Mason Investment Advisory Services Reston, Virginia $2.17B AUM 28.39% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
IIP
Intermede Investment Partners London, United Kingdom $2.16B AUM 18.47% 1-Year Est. Return

Invenomic Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Invenomic Capital Management held 190 positions worth $2.05B, up 9.3% from $1.88B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Invenomic Capital Management deployed $354M of net new capital in Q2 2024, opening 45 new positions and adding to 56 existing holdings. Its largest new stake was Solventum: 824,185 shares worth $43.6M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was 3M, an estimated $38.8M trimmed.

  • Invenomic Capital Management's largest Q2 2024 buy was Solventum: 824,185 shares worth $43.6M.
  • Invenomic Capital Management added most to Global Payments in Q2 2024, an estimated $29.6M increase.
  • Invenomic Capital Management's biggest Q2 2024 reduction was 3M, cutting an estimated $38.8M.
  • Invenomic Capital Management fully exited Archer Daniels Midland in Q2 2024, selling an estimated $37.9M.
  • Invenomic Capital Management's ten largest holdings make up 26% of its $2.05B portfolio in Q2 2024.
  • Invenomic Capital Management opened 45 new positions and closed 32 in Q2 2024.
  • Invenomic Capital Management's portfolio value rose 9.3% quarter-over-quarter to $2.05B.

Based on Invenomic Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.